Peloton Interactive Inc vs Viatris Inc — how do they compare? Peloton Interactive Inc trades at $5.06 (market cap $2.21B), while Viatris Inc trades at $16.45 (market cap $19.09B). The key difference: Viatris Inc is far larger — about 8.6× Peloton Interactive Inc's market cap, and Viatris Inc pays a 2.89% dividend while Peloton Interactive Inc pays none. Which is the better fit depends on your goals.
| PTON | VTRS | |
|---|---|---|
Market Cap | $2.21B | $19.09B |
Sector | Consumer Cyclical | Health |
52-Week High | $9.00 | $17.86 |
52-Week Low | $3.71 | $9.49 |
Enterprise Value | $2.71B | $31.21B |
Dividend Yield | — | 2.89% |
Signals from Pluang's Aura AI — not financial advice
Peloton Interactive (PTON) trades at $5.04, down 6.67% amid bearish technical signals and mixed fundamentals. The company achieved its first full-year net profit in fiscal 2026 with a 2.58% net income margin, though revenue declined to $2.49B in 2025. Analyst sentiment is divided with a 50% buy rating but a consensus price target of $7.25, while technical indicators show strong bearish momentum with all moving averages signaling sell.
The outlook remains cautious as PTON balances profitability gains against subscriber declines and weak revenue growth. Investment opportunity exists if cost-cutting sustains margins, but risks include high debt load, competitive pressures, and insider selling activity. The stock trades near key support levels with institutional sentiment mixed.
Viatris (VTRS) trades at $16.61, down 1.6% over the past 24 hours. The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported a net loss of $3.51 billion in 2025 despite revenue of $14.30 billion, though recent quarters have shown earnings beats. Positive cash flow generation and a dividend payment highlight financial stability, while analyst sentiment is mixed with a majority hold rating.
The outlook for VTRS hinges on its ability to return to profitability and sustain operational improvements. Investment opportunities include strong cash flow, deleveraging progress, and pipeline developments, but risks involve persistent net losses, competitive pressures, and potential regulatory impacts from proposed generic drug tariffs.
Trailing returns across standard periods
Latest headlines on both assets
Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →